Article Text

Download PDFPDF
Immunotherapy responsive startle with antibodies to voltage gated potassium channels
  1. Carlo Antozzi1,
  2. Simona Binelli2,
  3. Carolina Frassoni3,
  4. Claudia Ciano4,
  5. Angela Vincent5,
  6. Francesca Andreetta6,
  7. Ferruccio Panzica7,
  8. Silvana Franceschetti7,
  9. Paolo Confalonieri8,
  10. Renato Mantegazza8
  1. 1
    Myopathology and Immunology Unit, Neurological Institute Foundation “C Besta”, Milan, Italy
  2. 2
    Clinical Neurophysiology Unit, Neurological Institute Foundation “C Besta”, Milan, Italy
  3. 3
    Experimental Neurophysiology Unit, Neurological Institute Foundation “C Besta”, Milan, Italy
  4. 4
    Clinical Neurophysiology Unit, Neurological Institute Foundation “C Besta”, Milan, Italy
  5. 5
    Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, UK
  6. 6
    Myopathology and Immunology Unit, Neurological Institute Foundation “C Besta”, Milan, Italy
  7. 7
    Clinical Neurophysiology Unit, Neurological Institute Foundation “C Besta”, Milan, Italy
  8. 8
    Myopathology and Immunology Unit, Neurological Institute Foundation “C Besta”, Milan, Italy
  1. Dr Carlo Antozzi, Neuroimmunology and Muscle Pathology Unit, Neurological Institute Foundation “C Besta”, Via Celoria 11, 20133 Milan, Italy; antozzi{at}istituto-besta.it

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Antibodies to potassium channels (VGKC-Ab) were first associated with acquired neuromyotonia and its variant with CNS involvement, Morvan’s syndrome.1 Recently, VGKC-Ab were found in patients with non-paraneoplastic limbic encephalitis (LE), characterised by personality changes, seizures and memory impairment.2 These patients may respond to immunotherapies. Thus the association of VGKC-Ab and non-paraneoplastic LE established the concept of a potentially reversible autoimmune encephalopathy.2 We describe a patient with startle syndrome and VGKC-Ab, without neuromyotonia or LE, who responded dramatically to plasma exchange (PE) and immunosuppression, adding to the spectrum of disorders associated with VGKC-Ab.

The patient was a 54-year-old female. Hypothyroidism was diagnosed at the age of 30 years. At the age of 52 years, sudden falls without loss of consciousness occurred. Two months later, massive muscle jerks appeared, spontaneously or elicited by auditory and somatosensory stimuli. The frequency of jerks increased during the ensuing months, together with mild gait impairment and scanning speech. Brain MRI was normal; CSF was normal except for the presence of oligoclonal bands. Prednisone (50 mg/day), gabapentin and levetiracetam were prescribed without improvement. Low doses of clonazepam were poorly tolerated and not effective. She was admitted to our institution in December 2003. Physical examination showed spontaneous and stimuli induced massive limb jerking, very …

View Full Text

Footnotes

  • Competing interests: Professor A Vincent’s department receives payments and royalties for VGKC antibody assays. The other authors have not received any financial support from manufacturers of drugs or products cited in this manuscript.